| ||
| Give Cancer Patients a Choice Litchfield County Times In December, the FDA sided with its panel—and started the necessary steps to withdraw Avastin for advanced breast cancer. Avastin's developer, Genentech, has appealed the decision, and the FDA will render its final judgment later this month. ... See all stories on this topic » | ||
| Obese? Bariatric surgery can help Times of India A study from an Indian university has also concluded that the higher prevalence of severe obesity among Indian population may be associated with breast cancer. Surgery is the most effective treatment for morbid obesity, producing durable weight loss, ... See all stories on this topic » | ||
| Mitomics Launches Flagship Product – Prostate Core Mitomic Test™ Vancouver Sun "With the high rate of false negatives, uncertainty associated with traditional diagnostic tools, whether biochemical or histopathologic, and ongoing controversy regarding treatment paradigms, men at risk for prostate cancer are in need of new options ... See all stories on this topic » | ||
| Community Calendar ElmLeaves Illinois Breast and Cervical Cancer Program: Free pelvic exams and Pap tests along with mammography and breast exams offered to uninsured women in Illinois, regardless of income. To enroll in program, call (888) 522-1282 or visit ... See all stories on this topic » |
| ||
| Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual ... Entinostat is being studied in advanced breast cancer in combination with aromatase inhibitors and recently completed a randomized, placebo-controlled phase 2 trial in this patient population. ... Such genes are frequently silenced in cancer cells through the over-expression of enzymes including HDACs. HDACs are therefore recognized as promising targets for cancer treatment. Further, studies have demonstrated that HDAC inhibition can significantly enhance anti- cancer ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html | ||
| New Approach to Immune Therapy Shows Promise against - University ... The drug was given in combination with Gemzar® (gemcitabine) to 21 patients with advanced pancreatic cancer. Information about response to treatment was available for 19 patients: four of the patients experienced a partial reduction in ... University of Florida Shands... - http://cancer.ufl.edu/ | ||
| Podcast: Student Innovation Holds Promise for Breast Cancer ... Imagine a fast, inexpensive method for breast cancer screening. That's some of the promise behind a new innovation from a doctoral student who has discovered a way to use ultrasound and advanced algorithms to differentiate between ... Diagnostic Imaging - http://www.diagnosticimaging.com/ | ||
| New Approach to Immune Therapy Shows Promise against Pancreatic ... By Cancerconnect The drug was given in combination with Gemzar® (gemcitabine) to 21 patients with advanced pancreatic cancer. Information about response to treatment was available for 19 patients: four of the patients experienced a partial reduction in ... the National Cancer Institute (cancer.gov) as well as eCancerTrials.com. Reference: Beatty G, Chiroean EG, Fishman MP et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. ... CancerConnect News - http://news.cancerconnect.com/ | ||
| License extension application submitted in EU for cetuximab as ... A license extension application has been submitted in the EU for use of cetuximab in combination with standard first line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with high epidermal ... NICE issues guidance on bevacizumab in combination with a taxane for the first-line treatment of breast cancer. 23/02/2011. NICE issues guidance on pazopanib for the first-line treatment of metastatic renal cell carcinoma ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ | ||
| Major FDA Approval Could Pave the Way for These 5 Biotechs | www ... By marketmaker Pharmalot submits: In a widely anticipated move, the FDA has approved a Bristol- Myers Squibb (BMY) medication called Yervoy for treating advanced melanoma, which is the deadliest form of skin cancer. ... WASHINGTON – More than a decade after first gaining approval as a breast cancer treatment – and the first-ever drug approved with a companion diagnostic – Genentech Inc.'s targeted therapy Herceptin (trastuzumab) plus chemotherapy won the FDA's OK Wednesday night to treat ... Bullfax.com - Market News & Analysis - http://www.bullfax.com/ | ||
| AAA-Fund Blog » The value of our teachers By Caroline Because breast cancer viagra grande bretagne the person receiving treatment also has to do are Squat, Sprint, Push Up and Dips. To Soon Look at your list of just how much can be cialis pris accelerated by conversion of testosterone in ... Data Driven Tests Using viagra sin receta medica Multiple and Reusable Actions Using Database Checkpoints Object Repository Administration and Maintenance Using Recovery ScenariosIntroduction to Advanced QTP Introduction to the breath. ... AAA-Fund Blog - http://www.aaa-fund.com/ |
| ||
| TCM treatment of nasopharyngeal carcinoma is very therapeutic ... Traditional Chinese Medicine(TCM) Breast cancer treatment lung cancer mesothelioma Cancer ... Treatment for advanced breast cancer by TCM and western ... www.cancer-c.com/nasopharyngeal-carcinoma | ||
| You Certainly Did Not Know This Much Concerning Breast Cancer ... Metastatic breast cancer is actually type which includes advanced it's stage. ... The correct combination of treatment options can help you help save a ... babolat007.multiply.com/journal/item/979 | ||
| Significant survival improvement of patients with recurrent breast ... inhibitors (AI) recently became available for the treatment of breast cancer, and a number of randomized trials in postmenopausal women with advanced breast ... www.biomedcentral.com/content/pdf/1471-2407-11-118.pdf | ||
| Molecular Predictors of Response to Therapy for Breast Cance ... Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. ... journals.lww.com/.../Molecular_Predictors_of_Response_to_T... | ||
| Is Capecitabine Efficacious in Triple Negative Metastatic Breast ... ... with locally advanced or metastatic breast cancer treated in our unit. ... is a treatment option for patients with TN tumours in advanced disease ... content.karger.com/produktedb/produkte.asp?doi=323175 |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment